CoDiagnostics Inc Announces Recent Grant Awards

PRNewswire Salt Lake City (Utah) [US], July 19: Co-Diagnostics, Inc. (Nasdaq: CODX) (the “Company” or “Co-Dx”), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced grants awarded by the Bill & Melinda Gates Foundation related to the tuberculosis (TB) and human…Read More